305 related articles for article (PubMed ID: 1970851)
1. Neurochemical and neural mechanisms of positive and negative symptoms in schizophrenia.
Pickar D; Litman RE; Konicki PE; Wolkowitz OM; Breier A
Mod Probl Pharmacopsychiatry; 1990; 24():124-51. PubMed ID: 1970851
[TBL] [Abstract][Full Text] [Related]
2. Monoamines and schizophrenia.
Sedvall G
Acta Psychiatr Scand Suppl; 1990; 358():7-13. PubMed ID: 1978495
[TBL] [Abstract][Full Text] [Related]
3. Plasma homovanillic acid as an index of central dopaminergic activity: studies in schizophrenic patients.
Pickar D; Breier A; Kelsoe J
Ann N Y Acad Sci; 1988; 537():339-46. PubMed ID: 2904783
[TBL] [Abstract][Full Text] [Related]
4. Neurobiology of schizophrenic syndromes.
Garza-Treviño ES; Volkow ND; Cancro R; Contreras S
Hosp Community Psychiatry; 1990 Sep; 41(9):971-80. PubMed ID: 1976589
[TBL] [Abstract][Full Text] [Related]
5. [Neurobiology of schizophrenia].
Henn FA
Schweiz Arch Neurol Psychiatr (1985); 1995; 146(5):224-9. PubMed ID: 8658103
[TBL] [Abstract][Full Text] [Related]
6. Neuroleptics, dopamine, and schizophrenia.
Pickar D
Psychiatr Clin North Am; 1986 Mar; 9(1):35-48. PubMed ID: 2870480
[TBL] [Abstract][Full Text] [Related]
7. Perspectives on a time-dependent model of neuroleptic action.
Pickar D
Schizophr Bull; 1988; 14(2):255-68. PubMed ID: 2904694
[TBL] [Abstract][Full Text] [Related]
8. The neurochemical circuitry of schizophrenia.
Carlsson A
Pharmacopsychiatry; 2006 Feb; 39 Suppl 1():S10-4. PubMed ID: 16508890
[TBL] [Abstract][Full Text] [Related]
9. Are there neurochemical indicators of risk for schizophrenia?
Csernansky JG; Newcomer JW
Schizophr Bull; 1994; 20(1):75-88. PubMed ID: 7910978
[TBL] [Abstract][Full Text] [Related]
10. The regulation of subcortical dopamine systems by the prefrontal cortex: interactions of central dopamine systems and the pathogenesis of schizophrenia.
Deutch AY
J Neural Transm Suppl; 1992; 36():61-89. PubMed ID: 1527521
[TBL] [Abstract][Full Text] [Related]
11. Dopamine, the prefrontal cortex and schizophrenia.
Knable MB; Weinberger DR
J Psychopharmacol; 1997; 11(2):123-31. PubMed ID: 9208376
[TBL] [Abstract][Full Text] [Related]
12. [Transmitter dysfunction in patients with schizophrenia. Significance for cognitive functioning and treatment].
Glenthøj BY; Mackeprang T; Bille AE; Hemmingsen RP
Ugeskr Laeger; 1999 Mar; 161(10):1391-8. PubMed ID: 10085745
[TBL] [Abstract][Full Text] [Related]
13. Cortical-striatal-thalamic circuits and brain glucose metabolic activity in 70 unmedicated male schizophrenic patients.
Siegel BV; Buchsbaum MS; Bunney WE; Gottschalk LA; Haier RJ; Lohr JB; Lottenberg S; Najafi A; Nuechterlein KH; Potkin SG
Am J Psychiatry; 1993 Sep; 150(9):1325-36. PubMed ID: 8352343
[TBL] [Abstract][Full Text] [Related]
14. Dopamine-Related Disruption of Functional Topography of Striatal Connections in Unmedicated Patients With Schizophrenia.
Horga G; Cassidy CM; Xu X; Moore H; Slifstein M; Van Snellenberg JX; Abi-Dargham A
JAMA Psychiatry; 2016 Aug; 73(8):862-70. PubMed ID: 27145361
[TBL] [Abstract][Full Text] [Related]
15. Dopamine in schizophrenia: a review and reconceptualization.
Davis KL; Kahn RS; Ko G; Davidson M
Am J Psychiatry; 1991 Nov; 148(11):1474-86. PubMed ID: 1681750
[TBL] [Abstract][Full Text] [Related]
16. A theoretical and neurophysiological consideration on the pathogenesis of positive symptoms of schizophrenia: implications of dopaminergic function in the emotional circuit.
Maeda H
Jpn J Psychiatry Neurol; 1994 Mar; 48(1):99-110. PubMed ID: 7933723
[TBL] [Abstract][Full Text] [Related]
17. [Current status of biochemical hypotheses in the pathogenesis of schizophrenia].
Kornhuber J; Weller M
Nervenarzt; 1994 Nov; 65(11):741-54. PubMed ID: 7816150
[TBL] [Abstract][Full Text] [Related]
18. Novel pharmacological approaches to the treatment of schizophrenia.
Fink-Jensen A
Dan Med Bull; 2000 Jun; 47(3):151-67. PubMed ID: 10913983
[TBL] [Abstract][Full Text] [Related]
19. A developmental perspective on the pathology and neurochemistry of the temporal lobe in schizophrenia.
Kerwin RW; Murray RM
Schizophr Res; 1992 Apr; 7(1):1-12. PubMed ID: 1350459
[TBL] [Abstract][Full Text] [Related]
20. [Hypofrontality and negative symptoms in schizophrenia: synthesis of anatomic and neuropsychological knowledge and ecological perspectives].
Semkovska M; Bédard MA; Stip E
Encephale; 2001; 27(5):405-15. PubMed ID: 11760690
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
